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OBJECTIVE: To analyze the frequency of human leukocyte antigens class II-DR in children and adolescents with
systemic lupus erythematosus.
PATIENTS AND METHODS: Fifty-five Brazilian systemic lupus erythematosus children and adolescents and 308
healthy individuals were studied. Gender, race, and age of onset of systemic lupus erythematosus were recorded. The human
leukocyte antigens typing of class II-DR was carried out by polymerase chain reaction amplification with sequence-specific
primers (PCR-SSP). Data were analyzed statistically using the chi square test with Yates’ correction, Fisher’s exact test, and
Bonferroni’s correction.
RESULTS: Human leukocyte antigen-DR 15 was the most frequently detected antigen in this group of children and
adolescents, and it also occurred more frequently in the female group, in children with onset of systemic lupus erythematosus
between 0 and 9 years and between 10 to 14 years, and in the Black race group, but these associations were not statistically
significants.
CONCLUSION: In this group of children and adolescents with a high degree of racial admixture, we could not verify
a significant association between human leukocyte antigens class II-DR and systemic lupus erythematosus.
DESCRIPTORS: Systemic lupus erythematosus. Human leukocyte antigens. Children and adolescents.
INTRODUCTION
A complex genetic and immuno-
logic network participates in the
pathogenesis of systemic lupus ery-
thematosus (SLE)1,2. Among the ge-
netic factors, the human leukocyte an-
tigens (HLA) have earned special at-
tention in the literature, and a series of
works have reported an increased fre-
quency of the HLA-DR2 (15/16), DR3
(17/18), DR7, and DR9 in patients with
SLE3-7.
The relationships established to
date between the HLA and SLE were
in adult populations or in mixed
populations of adults and children,
with few works in literature involving
only children.
The objective of this study was to
analyze the frequency of the HLA class
II-DR in Brazilian children and adoles-
cents with SLE.
PATIENTS  AND  METHODS
A total of 55 children and adoles-
cents with a diagnosis of SLE8 were
studied and followed up. Patients were
included in the study after informed
and written consent and following ap-
proval of the study by the ethics com-
mission. The patients’ demographic
characteristics are presented in table 1.
The control group comprised 308
healthy and unrelated individuals; it
was established using the DNA bank
from the Laboratory of Immunology of
the Heart Institute, Hospital das
Clínicas, Faculty of Medicine, Univer-
sity of São Paulo.
The typing of HLA class II-DR was
carried out by polymerase chain reac-
tion amplification with sequence-spe-
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cific primers (PCR-SSP). The method
was based on the procedure devel-
oped by Olerup and Zetterquist9.
Statistical analysis included the chi
square test with Yate’s correction of
continuity and Fisher’s exact test. Con-
fidence limits of 95% (P = 0.05) were
used. The significant results were mul-
tiplied by the total number of tested an-
tigens (14 antigens), thereby obtaining
a corrected value of P, termed Pc
(Bonferroni’s correction)10-12.
RESULTS
In this group of 55 Brazilian chil-
dren and adolescents with SLE, the
HLA-DR15 was detected most fre-
quently; it was present in 18 patients
(33%). The second most frequently de-
tected antigen was HLA-DR7, present
in 14 patients (26%), and the third was
HLA-DR13, present in 13 patients
(24%).
The comparisons between the fre-
quencies of HLA-DR in the group of
patients with SLE and in the control
group are presented in table 2.
It was not possible to establish an
association between HLA and the
group of children and adolescents with
SLE under study, in spite of the sug-
gestion of an association with HLA-
DR15 (P = 0.0186), which was not con-
firmed after Bonferroni’s correction
(Pc = 0.260).
In the 15 patients with age at dis-
ease onset between 0 and 9 years, HLA-
DR13 and HLA-DR15 were detected
most frequently (P = 0.309 and P = 1.0,
respectively) and were present in 33%
of the patients. In the 35 patients aged
between 10 and 14 years, HLA-DR15
was the most frequently detected (P =
0.978) and was present in 34% of the
patients. In the 5 patients with ages
between 15 and 19 years, HLA-DR13
(P = 0.581), HLA-DR4 (P = 0.258), and
HLA-DR7 (P = 0.592) were the most
frequently detected antigens.
The relationships between HLA-
DR, gender, and ethnic group are pre-
sented in table 3. HLA-DR 15 was the
most frequently detected antigen in the
female group and in the Black race
group, but again, after Bonferroni’s
correction, there was no association be-
tween HLA-DR and gender or ethnic
group.
Table 1 - Demographic characteristics of the 55 children and adolescents with
SLE.
Demographic characteristics
Sex (n) Female 46
Male 09
Age at disease onset (years) Mean / range 10.4 / 1 to 17
Age at disease onset   Stratified (n) 0 to 9 years (n=15) Female 14
Male 01
10 to 14 years (n=35) Female 29
Male 06
15 to 19 years (n=05) Female 03
Male 02
Age at inclusion to study (years) Mean / range 14 / 8 to 20
Follow up (years) Mean / range 3.5 / 1 to 13
Race – Caucasian (n = 25) Female 22
Male 03
Black (n = 07) Female 05
Male 02
Asian (n = 01) Female 01
Male 00
Mixed (n = 22) Female 18
Male 04
Table 2 - Frequency of HLA-DR in the 55 children and adolescents with SLE and
in the 308 individuals comprising the control group.
HLA-DR Patients  (n = 55) Controls  (n = 308)* P Pc
DR1 18% 22.2% 0.602 -
DR15 33% 18% 0.0186 0.260
DR16 4% 6.3% 0.550 -
DR17 15% 18.4% 0.606 -
DR18 0% 3.3% 0.370 -
DR4 20% 21.8% 0.867 -
DR11 13% 23.4% 0.112 -
DR12 5% 1.3% 0.0737 -
DR13 24% 27.7% 0.621 -
DR14 5% 7.5% 0.779 -
DR7 26% 21.8% 0.706 -
DR8 16% 10% 0.254 -
DR9 5% 5.4% 0.763 -
DR10 5% 2.9% 0.402 -
Blank 11% 5.2% 0.136 -
DR51 36% 23.8% 0.0696 -
DR52 62% 67.4% 0.532 -
DR53 51% 45.2% 0.518 -
Blank = Non-identified antigens
*Samples supplied by the DNA bank from the Laboratory of Immunology- Heart’s Institute,
Hospital das Clínicas, Faculty of Medicine, University of São Paulo13.
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DISCUSSION
One of the main problems in
analyzing the studies regarding HLA is
related to the methodology adopted. The
characterization of the HLA can be ac-
complished using the serologic method
(for detecting DR2) or PCR amplifica-
tion with sequence-specific primers (for
detecting DR15 and DR16) or using the
specific sequences of oligopeptides (for
detecting DRB1*1501 to 1506 and
DRB1*1601 to 1608). These techniques
have different sensitivities, which hin-
ders an effective comparison between the
studies.
The Brazilian population, and es-
pecially those who reside in the city
of São Paulo, is characterized by a
high degree of racial admixture. The
ethnic origin of these individuals is
very difficult to establish. The major-
ity possesses different percentages of
Caucasian, Black, and Amerindian
ancestry. Therefore, it is necessary to
determine which HLA are associated
with SLE in a population characterized
by this degree of miscegenation.
Despite exhaustive studies in pa-
tients with SLE, the sensitivity and
specificity of the associations between
HLA and SLE vary in the diverse stud-
ies and different ethnic groups, render-
ing the results inconclusive14,15. Analy-
sis of various studies suggests a strong
association between the HLA-B8/
DR3/DQ2/C4A0 and B7/DR2/DQ1
haplotypes and SLE3,15-24. HLA-DR2
(15/16) and HLA-DR3 (17/18), taken
individually, are also associated with
SLE, but the relative risk conferred by
these is low (from 2 to 3)16.
SLE is rare in childhood, yet the
risk of SLE in the children of patients
with SLE is about 10%, demonstrating
a genetic component of the disease.
In infants, SLE develops with clini-
cal manifestations that maintain some
differences when compared to those
observed in adults1,2. These differences
in manifestation raise some questions
regarding the possibility that SLE in
childhood is a disease with its indi-
vidual genetic characteristics and may
be different from SLE in adults.
Lehman et al.25 studied 71 children
with SLE and observed that the onset
of the disease before 10 years of age
was strongly related to the presence of
antibodies to Ro/SSA in the maternal
blood, suggesting that the antibody to
Ro/SSA can influence the immunologi-
cal development of the fetus.
In this group of children with SLE,
we observed that the distribution of
the various HLA-DR was similar to the
control group, except for HLA-DR15
which was present in 33% of the chil-
dren with SLE and in 18% of the con-
trol group; however, this relationship
was not statistically significant after
Bonferroni’s correction (P = 0.0186
and Pc = 0.260). HLA-DR7 and DR13
were the second and the third most fre-
quently detected antigens, respec-
tively, but again, these correlations
were not statistically significant.
In Brazil, Silva et al.26 studying 93
patients with SLE with ages between
13 and 66 years, observed a higher fre-
quency of HLA-DR3 (17/18) (P =
0.003), a result that differs from that
observed in our study and from that re-
ported by Fernandes et al.27 in a study
Table 3 - Frequency of HLA-DR in the 55 children and adolescents with SLE, according to gender and ethnic group.
HLA- DR Number of patients Female Male Caucasian Black Asian Mixed
DR1 10 7 3 (P=0.339) 8 (P=0.0315 - - 2
Pc=0.412)
DR 15 18 17 (P=0.240) 1 7 5 (P=0.0316 - 6
Pc=0.412)
DR 16 2 2 - 2 - - -
DR 17 8 5 3 (P=0.113) 4 1 - 3
DR 18 0 - - - - - -
DR 4 11 9 2 8 (P=0.0905) - - 3
DR 11 7 7 - 2 2 - 3
DR 12 3 3 - 1 - - 2
DR 13 13 10 3 (P=0.427) 4 3 - 6
DR 14 3 3 - 2 - - 1
DR 7 14 11 3 (P=0.678) 4 2 - 8 (P=0.229)
DR 8 9 7 2 3 1 1 4
DR 9 3 3 - 1 - - 2
DR 10 3 3 - 2 - - 1
Blank 6 5 1 2 - 1 3
DR 51 20 19 1 9 5 - 6
DR 52 34 28 6 13 6 - 15
DR 53 28 23 5 13 2 - 13
Total 55 46 9 25 7 1 22
Blank = Non-identified antigens
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with 56 adult SLE patients, in which
HLA-DR2 (15/16) was the most fre-
quently detected antigen (P <0.005).
The association of HLA-DR7 and
HLA-DR13 with SLE was observed in
a few studies, such as that by Wilson
et al.7 in African Americans and that by
Cowland et al.28 in Denmark.
Regarding the age of SLE onset,
some authors describe an increased fre-
quency of the HLA-B8/DR3/DQ2/
C4A0 haplotype in patients among
which the onset of the disease occurred
after 35 years of age. Other authors
have described an increased frequency
of the HLA-B7/DR2/DQ1 haplotype in
patients whose SLE appeared before
25 years of age and that presented se-
rious nephritis3. However, Barron et
al.29 in a study of children with SLE
did not corroborate these findings.
Likewise, we did not observe any
relationship between the age at onset
of SLE and HLA. However, all of our
patients presented onset of the SLE
before 25 years of age, and HLA-DR2
(15/16) was present in 37%, therefore
demonstrating a behavior similar to
that described above.
It is interesting to underscore that
in this study, HLA-DR15 was the most
frequently detected antigen in the 0 to
9-year-old and 10 to 14-year-old age
groups, but this was not the case
among the adolescents from 15 to 18
years of age.
The associations between the HLA
and SLE vary between the different eth-
nic groups. HLA-DR3 is associated
with SLE in Caucasians, and HLA-DR2
is associated with Black, Chinese, and
Japanese populations6,15. In Caucasian
children with SLE, an association was
observed with HLA-DR3(DRB1*0301),
and in Blacks, there was an association
with HLA-DR2(DRB1*1503/
DRB1*1501) / DRB5*0101 /
DQA1*0102 / DQB1*060229.
In our study, HLA-DR1 and HLA-
DR4 were the most frequently detected
antigens in the Caucasian patients.
There is no report of an association be-
tween HLA-DR1 and SLE in the litera-
ture, either among Caucasians, Black,
or Asians6, while HLA-DR4 is de-
scribed as being associated with SLE
only in Indians30. According to the lit-
erature, 75% of Caucasian patients
with SLE present the HLA-DR2 and/
or HLA-DR3 antigens. We observed
that 52% of our Caucasian patients
presented these antigens.
HLA-DR15 was the most frequently
antigen in the Black race patients of this
study. The HLA-DR2 (15/16) has been
associated with Black race SLE patients
both in Black race people from America
as from South Africa24, 31, 32.
Among the Asian patients, an asso-
ciation has been described between
SLE and HLA-DR9 in Chinese pa-
tients from Singapore 5 and in Kore-
ans20 and with HLA-DR15 in Japa-
nese19, Chinese23, and Korean pa-
tients20. Our only Asian patient pre-
sented HLA-DR8 in homozygosis.
There is no association described be-
tween SLE and HLA-DR8.
In the patients of the mixed-race
group, HLA-DR7 was the most fre-
quently occurring antigen. There are
descriptions of an association between
HLA-DR7 and SLE only in Black race
people from America6,7.
It is interesting to observe that in
our study, there was a prevalence of
HLA-DR7 in the mixed-race group and
of HLA-DR15 in the Black race group,
suggesting that perhaps the group con-
sidered to be mixed race here may in
fact not be characterized by a predomi-
nant miscegenation of Black race with
other races.
In the present study, we observed
associations between HLA and SLE
ethnic groups that were different from
those observed in the literature. This
difference is probably due to the fact,
as already stated, that racial admixture
in Brazil is very prominent, which hin-
ders a comparison of our ethnic groups
with those of other countries. (Table 4)
SLE occurs more frequently among
women, mainly after puberty, with a
female:male ratio of 8:1. The higher in-
cidence of SLE in women has been as-
sociated with hormonal factors, such as
estrogen, which could influence the on-
set of this pathology. In children, female
prevalence also occurs; perhaps genetic
factors, especially concerning HLA,
could have some influence on the higher
incidence of SLE in the female sex. The
ratio between the female and male sex
among the children and adolescents
with SLE in this study was 5.1:1, a find-
ing similar to the ratio reported in the
Table 4 - Relationship between the HLA and SLE racial groups.
Author Ethnic Groups
Caucasian Black Asian Mixed
Arnett3 HLA-DR2/DR3 - - -
Fernades et al.27 HLA-DR2 - - -
Reivelle et al.32 - HLA-DR2 - -
Rudwaleit et al.31 - HLA-DR2 - -
Barron et al. 29 HLA-DR3 HLA-DR2 - -
Rudwalet et al. 5 and Hong et al.20 - - HLA-DR9 -
Hashimoto et al.19 and  Doherty et al.23 - - HLA-DR15 (2) -
Wilson et al.7 - HLA-DR7 - -
Liphaus (present study) HLA-DR1/DR4 HLA-DR15 (2) HLA-DR8 HLA-DR7
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literature, and there was a uniform dis-
tribution of HLA-DR in both the female
and male groups. (Table 3)
The majority of studies do not re-
port a relationship between the HLA
and gender; however, Doherty et al.23
observed that the HLA-DR15 antigen
was detected in all the men in their
study population.
In view of the discrepancies ob-
served in the various studies referred to
in the literature, it is possible that HLA
have little or no influence on the mecha-
nisms of etiopathology of SLE. While
possible, this fact seems improbable be-
cause of the close relationship between
HLA and the immunological system.
Perhaps in the near future, methods with
greater sensitivity and more specific
probes will establish clearer correla-
tions than those seen to date.
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OBJETIVO: Analisar a freqüência
dos antígenos de histocompatibi-
lidade leucocitária de classe II-DR em
crianças e adolescentes com o lúpus
eritematoso sistêmico.
PACIENTES E MÉTODOS: Cin-
qüenta e cinco crianças e adolescen-
tes lúpicos brasileiros e 308 indivídu-
os sadios foram estudados. Os sexos,
os grupos étnicos e as idades de iní-
cio da doença foram anotados. A
tipagem de histocompatibilidade
leucocitária de classe II-DR foi reali-
zada pela reação de polimerase em ca-
deia com amplificação de sondas de
seqüência específica (PCR-SSP). Na
análise estatística foram utilizados o
teste de qui-quadrado com correção de
Yates, o teste exato de Fisher e a cor-
reção de Bonferroni.
RESULTADOS: A histocompati-
bilidade leucocitária-DR15 foi a mais
freqüente neste grupo de crianças e
adolescentes, sendo também mais fre-
qüente nas mulheres, nas crianças com
idade de início da doença entre zero e
nove anos e entre 10 e 14 anos e nas
crianças de raça negra, mas estas cor-
relações não foram estatisticamente
significativas.
CONCLUSÃO: Neste grupo de cri-
anças e adolescentes com alto grau de
miscigenação não pudemos observar
associação significativa entre os
antígenos de histocompatibilidade
leucocitária de classe II-DR e o lúpus
eritematoso sistêmico.
DESCRITORES: Lúpus eritema-
toso sistêmico. Antígenos de histo-
compatibilidade leucocitária. Crian-
ças e adolescentes.
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